Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Invested Capital: 2019-2024

  • Anaptysbio's Return on Invested Capital rose 10.00% to -1.48% in Q4 2024 from the same period last year, while for Dec 2024 it was -1.48%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.94% for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2024, Anaptysbio's Return on Invested Capital is -1.48%, which was up 73.70% from -5.63% recorded in Q2 2024.
  • Over the past 5 years, Anaptysbio's Return on Invested Capital peaked at -1.48% during Q4 2024, and registered a low of -5.63% during Q2 2024.
  • Over the past 2 years, Anaptysbio's median Return on Invested Capital value was -1.58% (recorded in 2023), while the average stood at -2.90%.
  • Data for Anaptysbio's Return on Invested Capital shows a peak YoY rose of 10bps (in 2024) over the last 5 years.
  • Over the past 2 years, Anaptysbio's Return on Invested Capital (Quarterly) stood at -1.58% in 2023, then climbed by 10bps to -1.48% in 2024.
  • Its Return on Invested Capital stands at -1.48% for Q4 2024, versus -5.63% for Q2 2024 and -1.58% for Q4 2023.